替考拉宁临床应用合理性评价  

Evaluation of rationality of clinical application of teicoplanin

作　　者：谢永忠[1] 赵阳昱[1] 吴睿[1] 庄仲侠[1] 

机构地区：[1]黄山市人民医院药剂科,安徽黄山245000

出　　处：《中华医院感染学杂志》2013年第15期3745-3746,3749,共3页Chinese Journal of Nosocomiology

摘　　要：目的了解临床替考拉宁的使用与评价其用药的合理性,为替考拉宁合理应用与管理提供参考依据。方法调查使用替考拉宁住院病例155份,填写评价表,依据评价标准并对结果进行统计分析。结果 155例应用替考拉宁治疗患者以肺部感染为主,占81.29%;微生物标本送检率为78.71%,以痰标本为主,占84.42%;药物利用指数(DUI)<1;155例中合理或基本合理用药占的72.90%,不合理用药占27.10%。结论临床不合理使用替考拉宁现象较普遍,主要表现在起始治疗未予负荷量、疗程不符合要求、适应证不强,有待规范。OBJECTIVE To understand the application status of teicoplanin in clinic and to evaluate its rationality so as to provide reference for the reasonable clinical application of teicoplanin. METHODS The medical records of 155 hospitalized patients who used antibiotics were investigated, the tables of evaluation were filled out, and the results were statistically analyzed according to the evaluation standard. RESULTS Of the 155 eases of patients who were treated with teicoplanin, the patients with pulmonary infections accounted for 81.29%. The submission rate of microbial specimens was 78.71%, and the sputum was the main specimens source, accounting for 84.420%;the DUI was less than 1. Of all the 155 cases, the cases who used the antibiotics reasonably or basically reasonably ac- counted for 72.90%, the cases who did not use reasonably 27.10%. CONCLUSION The unreasonable use of teico- planin exists widely, mostly presenting at not giving the load dose in initial treatment, the course of treatment without conforming to the requirement, the relaxed indications, which need to be standardized..

关 键 词：替考拉宁 评价标准 合理性 负荷量 

分 类 号：R978.1[医药卫生—药品]